MediPal Holdings Corporation (MEPDF)
OTCMKTS · Delayed Price · Currency is USD
19.00
0.00 (0.00%)
At close: Feb 4, 2026
MediPal Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 3,775,823 | 3,671,328 | 3,558,732 | 3,360,008 | 3,290,921 | 3,211,125 | |
Revenue Growth (YoY) | 3.42% | 3.16% | 5.91% | 2.10% | 2.48% | -1.29% |
Cost of Revenue | 3,515,267 | 3,415,569 | 3,312,077 | 3,135,703 | 3,073,476 | 2,996,864 |
Gross Profit | 260,556 | 255,759 | 246,655 | 224,305 | 217,445 | 214,261 |
Selling, General & Admin | 193,601 | 186,634 | 185,677 | 163,143 | 159,487 | 162,908 |
Operating Expenses | 207,133 | 200,148 | 199,324 | 175,331 | 171,820 | 175,683 |
Operating Income | 53,423 | 55,611 | 47,331 | 48,974 | 45,625 | 38,578 |
Interest Expense | -11 | -7 | -8 | -34 | -16 | -50 |
Interest & Investment Income | 7,152 | 3,142 | 2,790 | 2,635 | 2,708 | 2,845 |
Earnings From Equity Investments | -1,166 | -3,768 | 3,584 | 3,590 | 3,484 | 2,439 |
Other Non Operating Income (Expenses) | 10,418 | 10,275 | 10,873 | 9,957 | 10,243 | 9,155 |
EBT Excluding Unusual Items | 69,816 | 65,253 | 64,570 | 65,122 | 62,044 | 52,967 |
Gain (Loss) on Sale of Investments | 12,771 | 11,819 | 9,764 | 6,855 | -917 | 8,818 |
Gain (Loss) on Sale of Assets | -479 | -397 | -141 | -147 | -32 | 573 |
Asset Writedown | -411 | -278 | -707 | -266 | -100 | -1,580 |
Other Unusual Items | 205 | 335 | 1,254 | -1,503 | -3,713 | -11,542 |
Pretax Income | 77,367 | 76,732 | 74,740 | 70,061 | 57,282 | 49,236 |
Income Tax Expense | 25,260 | 25,203 | 22,973 | 21,738 | 18,087 | 15,621 |
Earnings From Continuing Operations | 52,107 | 51,529 | 51,767 | 48,323 | 39,195 | 33,615 |
Minority Interest in Earnings | -10,652 | -11,250 | -10,293 | -9,517 | -9,772 | -9,689 |
Net Income | 41,455 | 40,279 | 41,474 | 38,806 | 29,423 | 23,926 |
Net Income to Common | 41,455 | 40,279 | 41,474 | 38,806 | 29,423 | 23,926 |
Net Income Growth | -16.13% | -2.88% | 6.88% | 31.89% | 22.98% | -36.98% |
Shares Outstanding (Basic) | 205 | 208 | 212 | 210 | 210 | 210 |
Shares Outstanding (Diluted) | 205 | 208 | 212 | 216 | 223 | 223 |
Shares Change (YoY) | -2.06% | -1.55% | -2.11% | -3.04% | 0.03% | -2.60% |
EPS (Basic) | 200.64 | 193.19 | 195.83 | 184.82 | 140.13 | 113.95 |
EPS (Diluted) | 200.64 | 193.19 | 195.83 | 179.12 | 131.41 | 106.80 |
EPS Growth | -15.16% | -1.35% | 9.33% | 36.31% | 23.04% | -35.40% |
Free Cash Flow | - | 51,698 | 46,283 | 5,663 | 45,258 | 21,606 |
Free Cash Flow Per Share | - | 247.96 | 218.54 | 26.18 | 202.84 | 96.86 |
Dividend Per Share | 64.000 | 62.000 | 60.000 | 46.000 | 44.000 | 42.000 |
Dividend Growth | 6.67% | 3.33% | 30.44% | 4.54% | 4.76% | 2.44% |
Gross Margin | - | 6.97% | 6.93% | 6.68% | 6.61% | 6.67% |
Operating Margin | 1.42% | 1.52% | 1.33% | 1.46% | 1.39% | 1.20% |
Profit Margin | 1.10% | 1.10% | 1.17% | 1.16% | 0.89% | 0.74% |
Free Cash Flow Margin | - | 1.41% | 1.30% | 0.17% | 1.38% | 0.67% |
EBITDA | 72,166 | 74,028 | 65,313 | 63,622 | 59,963 | 53,370 |
EBITDA Margin | - | 2.02% | 1.84% | 1.89% | 1.82% | 1.66% |
D&A For EBITDA | 18,743 | 18,417 | 17,982 | 14,648 | 14,338 | 14,792 |
EBIT | 53,423 | 55,611 | 47,331 | 48,974 | 45,625 | 38,578 |
EBIT Margin | - | 1.52% | 1.33% | 1.46% | 1.39% | 1.20% |
Effective Tax Rate | - | 32.84% | 30.74% | 31.03% | 31.57% | 31.73% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.